chitosan has been researched along with Hepatitis E in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baha, S; Behloul, N; Liu, Z; Meng, J; Shi, R; Wang, W; Wei, W | 1 |
| Fu, T; He, ZJ; Hong, Y; Tao, W; Zheng, HQ | 1 |
2 other study(ies) available for chitosan and Hepatitis E
| Article | Year |
|---|---|
Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E.
Topics: Adjuvants, Immunologic; Animals; Chitosan; Escherichia coli; Female; Hepatitis E; Immunity, Cellular; Immunization; Immunoglobulin G; In Vitro Techniques; Interleukin-4; Lymphocytes; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Peptides; RNA, Messenger; Spleen; Vaccine Development; Viral Hepatitis Vaccines; Viral Proteins | 2021 |
N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.
Topics: Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chitosan; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Immunity, Cellular; Immunity, Humoral; Immunogenicity, Vaccine; Immunoglobulin G; Mice; Mice, Inbred BALB C; Peptides; Quaternary Ammonium Compounds; Vaccination; Vaccines, Synthetic; Viral Hepatitis Vaccines | 2017 |